Low plasma exosome-derived BTG-1 levels were observed in the poor differentiation group and were associated with abnormal CEA levels, tumor diameter greater than or equal to 5 cm, stage III disease, and lymph node metastasis. Here, BTG1 is linked to neoplasm.